•  
  •  
 

Abstract

Antibiotic treatment improves outcomes of treatment, but extensively available antibiotics efficiency is vulnerable by globally appearance of development of multidrug-resistant bacteria. An infectious etiology arises, such as fungi, bacteria, viruses, mycobacteria, or parasites, or be related with cancer, autoimmunity, or medications reaction. The causative organism was recognized by most patients treated with antibiotics, culture of the CSF and blood, by countercurrent immune-electrophoresis of fluids. Neisseria meningitidis, Hemophilus influenzae b and Streptococcus pneumoniae are the commonest causes of bacterial meningitis. Bacterial meningitis has adequately extreme in the pediatrics people of developing countries. Many people with bacterial meningitis don't have any permanent problems as with quick treatment. Thus, with rapid treatment, some may have sensorineural hearing loss, seizures, brain injury and disabilities. The clinical indications include temperature, lethargy, asphyxia, rash and loss of consciousness. In older children, the more symptoms of chronic stiff, photophobia and headache are more common. The diagnosis of ABM recognized by clinical performance and results abnormal CSF, including elevated protein levels, polymorphonuclear-cell pleocytosis, and depressed glucose concentrations. Formulations of ceftriaxone are most available and reasonable and are effective against meningitis caused by chloramphenicol resistant bacteria and penicillin resistant. Infection with Streptococcus pneumoniae with condensed vulnerability to ceftriaxone is reported increasingly and replacements are too expensive (e.g., of vancomycin).

Article History

Received: Jan 23, 2022; Accepted: Jun 17, 2022; Published: March 30, 2025

Download


Share

COinS